Skip to main content

Table 3 Summary of medication taken by sample

From: Medication and psychotherapy in eating disorders: is there a gap between research and practice?

 

AN

 

AN-sub-threshold

 

BN

 

BN-sub-threshold

 

Total

 
 

(N = 44)

(N = 30)

(N = 126)

(N = 53)

(N = 253)

 

N

%

N

%

N

%

N

%

N

%

No medication

17

38.6

14

46.7

77

69.1

31

58.5

139

54.9

One psychiatric drug

14

31.8

9

30

22

17.5

8

15.1

53

20.9

Two psychiatric drugs

5

11.4

3

10.0

13

10.3

5

9.4

26

10.3

Three psychiatric drugs

3

6.8

4

13.3

7

5.6

3

5.7

17

6.7

Four psychiatric drugs

4

9.1

0

0

2

1.6

2

3.8

8

3.2

Five psychiatric drugs

0

0

0

0

3

2.4

0

0

3

1.2

Total on any psychiatric medication

26

59.0

16

53.3

41

32.5

25

47.2

108

42.7

Anti-anxiety

7

15.9

5

16.7

12

9.5

6

11.3

36

14.2

Hypnotics

0

0

0

0

4

3.2

2

3.8

6

2.4

Psycho-stimulants

2

4.5

0

0

3

2.4

2

3.8

7

2.8

Tricyclic antidepressants

1

2.3

0

0

1

0.8

1

1.9

3

1.2

SSRIs

20

45.5

11

36.7

8

14.3

11

20.8

50

19.8

Fluoxetine

4

9.1

5

16.7

4

3.2

2

3.8

15

5.9

SARIs

2

4.5

0

0

3

2.4

0

0

5

2.0

SNRIs

1

2.3

2

6.7

15

11.9

3

3.8

21

8.3

NaSSRAs

1

2.3

1

3.3

4

3.2

1

1.9

7

2.8

NDRIs

1

2.3

0

0

5

4.0

0

0

6

2.4

Melatonergic agonists

0

0

0

0

1

0.8

0

0

1

0.4

Antidepressant (unspecified)

1

2.3

0

0

0

0

1

1.9

2

0.8

Total on anti-depressants

27

61.4

14

46.7

41

32.5

25

47.2

107

42.3

Mood stabilisers

3

6.8

4

13.3

16

12.7

3

3.8

26

10.3

Antipsychotics

7

15.9

2

6.7

8

6.3

4

7.5

21

8.3

  1. Key: AN Anorexia Nervosa, AN-sub-threshold, BN Bulimia Nervosa, BN-sub-threshold, SSRIs Selective Serotonin Reuptake Inhibitors, SARIs Serotonin Antagonist and Reuptake Inhibitor, SNRIs Serotonin Norepinephrine Reuptake Inhibitor, NaSSAs Noradrenergic and Specific Serotinergic Antidepressant, NDRIs Norepinephrine Dopamine Reuptake Inhibitor